<p>，/PRNewswire/ -- DJS 律師事務所宣佈正在代表 aTyr Pharma, Inc.（&#34;aTyr&#34;或&#34;公司&#34;）（NASDAQ: ATYR）的投資者調查索賠，涉及證券法的違反。</p>
<p><strong>調查詳情：</strong> 調查重點是公司是否發佈了誤導性聲明和/或未能披露與投資者相關的重要信息。2025 年 9 月 15 日，_路透社_報道説，&#34;aTyr Pharma 週一表示，其實驗藥物未能在一項針對患有肺部疾病（稱為肺肉芽腫病）的患者的晚期研究中達到主要目標，該疾病影響肺部和淋巴結。&#34; 根據這一消息，aTyr 的股票在同一天的早盤交易中下跌超過 81%。</p>
<p>如果您是遭受損失的股東，請聯繫我們參與。</p>
<p><strong>為什麼選擇 DJS 律師事務所？</strong> DJS 律師事務所的主要目標是通過平衡的諮詢和積極的倡導來提高投資者回報。我們專注於證券集體訴訟、公司治理訴訟以及國內/國際併購評估。我們的客户是全球一些最大和最複雜的對沖基金和另類資產管理公司。我們客户的訴訟索賠是極其有價值的資產，值得尊重、關注和結果。</p>
<p>本新聞稿在某些司法管轄區可能被視為律師廣告，依據適用法律和倫理規則。</p>
<p><strong>聯繫方式：</strong></p>
<p>David J. Schwartz</p>
<p>DJS 律師事務所</p>
<p>274 White Plains Road, Suite 1</p>
<p>Eastchester, NY 10709</p>
<p>電話：914-206-9742</p>
<p>電子郵件：[email protected]</p>
<p>來源：DJS 律師事務所 LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3"/></p>

LIFE

<p>DJS Law Group 正在調查 aTyr Pharma, Inc. 是否存在證券欺詐違規行為。調查的重點是 aTyr 是否發佈了誤導性聲明或未能披露重要信息。在一項藥物研究失敗的消息傳出後，aTyr 的股價下跌超過 81%。遭受損失的股東被鼓勵聯繫 DJS Law Group。該公司專注於證券集體訴訟和公司治理訴訟</p>

<p>, /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. (&#34;aTyr&#34; or &#34;the Company&#34;) (NASDAQ: ATYR) for violations of the securities laws.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- DJS 律師事務所宣佈正在代表 aTyr Pharma, Inc.（&#34;aTyr&#34;或&#34;公司&#34;）（NASDAQ: ATYR）的投資者調查索賠，涉及證券法的違反。</p>
</div><p><strong>INVESTIGATION DETAILS:</strong> The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On September 15, 2025, <em>Reuters</em> reported that, &#34;aTyr Pharma said on Monday its experimental drug had failed to meet the main goal in a late-stage study testing it in patients with a type of lung disease known as pulmonary sarcoidosis, which impacts the lungs and lymph nodes.&#34; Based on this news, shares of aTyr traded down by more than 81% in morning trading on the same day.</p>
<div class="lb-trans"><p><strong>調查詳情：</strong> 調查重點是公司是否發佈了誤導性聲明和/或未能披露與投資者相關的重要信息。2025 年 9 月 15 日，_路透社_報道説，&#34;aTyr Pharma 週一表示，其實驗藥物未能在一項針對患有肺部疾病（稱為肺肉芽腫病）的患者的晚期研究中達到主要目標，該疾病影響肺部和淋巴結。&#34; 根據這一消息，aTyr 的股票在同一天的早盤交易中下跌超過 81%。</p>
</div><p>If you are a shareholder who suffered a loss, contact us to participate.</p>
<div class="lb-trans"><p>如果您是遭受損失的股東，請聯繫我們參與。</p>
</div><p><strong>WHY DJS LAW GROUP?</strong> DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.</p>
<div class="lb-trans"><p><strong>為什麼選擇 DJS 律師事務所？</strong> DJS 律師事務所的主要目標是通過平衡的諮詢和積極的倡導來提高投資者回報。我們專注於證券集體訴訟、公司治理訴訟以及國內/國際併購評估。我們的客户是全球一些最大和最複雜的對沖基金和另類資產管理公司。我們客户的訴訟索賠是極其有價值的資產，值得尊重、關注和結果。</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.</p>
<div class="lb-trans"><p>本新聞稿在某些司法管轄區可能被視為律師廣告，依據適用法律和倫理規則。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>聯繫方式：</strong></p>
</div><p>David J. Schwartz</p>
<div class="lb-trans"><p>David J. Schwartz</p>
</div><p>DJS Law Group</p>
<div class="lb-trans"><p>DJS 律師事務所</p>
</div><p>274 White Plains Road, Suite 1</p>
<div class="lb-trans"><p>274 White Plains Road, Suite 1</p>
</div><p>Eastchester, NY 10709</p>
<div class="lb-trans"><p>Eastchester, NY 10709</p>
</div><p>Phone: 914-206-9742</p>
<div class="lb-trans"><p>電話：914-206-9742</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>SOURCE DJS Law Group LLP</p>
<div class="lb-trans"><p>來源：DJS 律師事務所 LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA41107&amp;Transmission_Id=202512080325PR_NEWS_USPR_____LA41107&amp;DateId=20251208"/></p>

aTyr Pharma, Inc. 因涉嫌證券欺詐違規行為被調查 - 請聯繫 DJS 律師事務所以討論您的權利 - ATYR